237 related articles for article (PubMed ID: 15089760)
1. Constitutive expression of the FK506 binding protein 51 (FKBP51) in bone marrow cells and megakaryocytes derived from idiopathic myelofibrosis and non-neoplastic haematopoiesis.
Bock O; Neusch M; Büsche G; Mengel M; Kreipe H
Eur J Haematol; 2004 Apr; 72(4):239-44. PubMed ID: 15089760
[TBL] [Abstract][Full Text] [Related]
2. Aberrant expression of transforming growth factor beta-1 (TGF beta-1) per se does not discriminate fibrotic from non-fibrotic chronic myeloproliferative disorders.
Bock O; Loch G; Schade U; von Wasielewski R; Schlué J; Kreipe H
J Pathol; 2005 Apr; 205(5):548-57. PubMed ID: 15726648
[TBL] [Abstract][Full Text] [Related]
3. Osteosclerosis in advanced chronic idiopathic myelofibrosis is associated with endothelial overexpression of osteoprotegerin.
Bock O; Loch G; Schade U; Büsche G; Wasielewski R; Wiese B; Kreipe H
Br J Haematol; 2005 Jul; 130(1):76-82. PubMed ID: 15982347
[TBL] [Abstract][Full Text] [Related]
4. Aberrant expression of beta-catenin discriminates acute myeloid leukaemia from acute lymphoblastic leukaemia.
Serinsöz E; Neusch M; Büsche G; Wasielewski R; Kreipe H; Bock O
Br J Haematol; 2004 Aug; 126(3):313-9. PubMed ID: 15257703
[TBL] [Abstract][Full Text] [Related]
5. Aberrant expression of insulin-like growth factor-2 (IGF-2) in Philadelphia chromosome negative chronic myeloproliferative disorders.
Bock O; Tessema M; Serinsöz E; von Wasielewski R; Büsche G; Kreipe H
Leuk Res; 2004 Nov; 28(11):1145-51. PubMed ID: 15380337
[TBL] [Abstract][Full Text] [Related]
6. Thrombopoietin receptor (Mpl) expression by megakaryocytes in myeloproliferative disorders.
Bock O; Schlué J; Mengel M; Büsche G; Serinsöz E; Kreipe H
J Pathol; 2004 May; 203(1):609-15. PubMed ID: 15095485
[TBL] [Abstract][Full Text] [Related]
7. Overexpression of FKBP51 in idiopathic myelofibrosis regulates the growth factor independence of megakaryocyte progenitors.
Giraudier S; Chagraoui H; Komura E; Barnache S; Blanchet B; LeCouedic JP; Smith DF; Larbret F; Taksin AL; Moreau-Gachelin F; Casadevall N; Tulliez M; Hulin A; Debili N; Vainchenker W
Blood; 2002 Oct; 100(8):2932-40. PubMed ID: 12351405
[TBL] [Abstract][Full Text] [Related]
8. Transcription factor Fli-1 expression by bone marrow cells in chronic myeloproliferative disorders is independent of an underlying JAK2 (V617F) mutation.
Bock O; Hussein K; Neusch M; Schlué J; Wiese B; Kreipe H
Eur J Haematol; 2006 Dec; 77(6):463-70. PubMed ID: 16930139
[TBL] [Abstract][Full Text] [Related]
9. Expression profiling of apoptosis-related genes in megakaryocytes: BNIP3 is downregulated in primary myelofibrosis.
Theophile K; Hussein K; Kreipe H; Bock O
Exp Hematol; 2008 Dec; 36(12):1728-38. PubMed ID: 18838203
[TBL] [Abstract][Full Text] [Related]
10. CD34+ progenitor cells in idiopathic (primary) myelofibrosis: a comparative quantification between spleen and bone marrow tissue.
Thiele J; Kvasnicka HM; Czieslick C
Ann Hematol; 2002 Feb; 81(2):86-9. PubMed ID: 11907788
[TBL] [Abstract][Full Text] [Related]
11. Role for the nuclear factor kappaB pathway in transforming growth factor-beta1 production in idiopathic myelofibrosis: possible relationship with FK506 binding protein 51 overexpression.
Komura E; Tonetti C; Penard-Lacronique V; Chagraoui H; Lacout C; Lecouédic JP; Rameau P; Debili N; Vainchenker W; Giraudier S
Cancer Res; 2005 Apr; 65(8):3281-9. PubMed ID: 15833861
[TBL] [Abstract][Full Text] [Related]
12. Early down-regulation of Bcl-xL expression during megakaryocytic differentiation of thrombopoietin-induced CD34+ bone marrow cells in essential thrombocythemia.
Zhang L; Zhao H; Sun A; Lu S; Liu B; Tang F; Feng Y; Zhao L; Yang R; Han ZC
Haematologica; 2004 Oct; 89(10):1199-206. PubMed ID: 15477204
[TBL] [Abstract][Full Text] [Related]
13. Quantitative analysis of growth factor production in the mechanism of fibrosis in agnogenic myeloid metaplasia.
Wang JC; Chang TH; Goldberg A; Novetsky AD; Lichter S; Lipton J
Exp Hematol; 2006 Dec; 34(12):1617-23. PubMed ID: 17157157
[TBL] [Abstract][Full Text] [Related]
14. Differential in vivo and in vitro expression of ED-B+ fibronectin in adult human hematopoiesis.
Vogel W; Berndt A; Müller A; Dahse R; Haas KM; Borsi L; Zardi L; Kosmehl H
Int J Mol Med; 2003 Dec; 12(6):831-7. PubMed ID: 14612953
[TBL] [Abstract][Full Text] [Related]
15. Differences in proportion and dynamics of recipient hematopoiesis following hematopoietic cell transplantation in CML and IMF.
Siebolts U; Thiele J; Zander T; Ditschkowski M; Beelen DW; Kröger N; Fehse B; Wickenhauser C
Oncol Rep; 2008 Jan; 19(1):287-92. PubMed ID: 18097609
[TBL] [Abstract][Full Text] [Related]
16. Increased Dkk3 protein expression in platelets and megakaryocytes of patients with myeloproliferative neoplasms.
Medinger M; Tzankov A; Kern J; Pircher A; Hermann M; Ott HW; Gastl G; Untergasser G; Gunsilius E
Thromb Haemost; 2011 Jan; 105(1):72-80. PubMed ID: 20978717
[TBL] [Abstract][Full Text] [Related]
17. Spontaneous STAT5 activation induces growth factor independence in idiopathic myelofibrosis: possible relationship with FKBP51 overexpression.
Komura E; Chagraoui H; Mansat de Mas V; Blanchet B; de Sepulveda P; Larbret F; Larghero J; Tulliez M; Debili N; Vainchenker W; Giraudier S
Exp Hematol; 2003 Jul; 31(7):622-30. PubMed ID: 12842707
[TBL] [Abstract][Full Text] [Related]
18. Thrombospondin-1 (TSP-1) in primary myelofibrosis (PMF) - a megakaryocyte-derived biomarker which largely discriminates PMF from essential thrombocythemia.
Muth M; Engelhardt BM; Kröger N; Hussein K; Schlué J; Büsche G; Kreipe HH; Bock O
Ann Hematol; 2011 Jan; 90(1):33-40. PubMed ID: 20625903
[TBL] [Abstract][Full Text] [Related]
19. Comparative analysis of hypermethylation of cell cycle control and DNA-mismatch repair genes in low-density and CD34+ bone marrow cells from patients with myelodysplastic syndrome.
Hofmann WK; Takeuchi S; Takeuchi N; Thiel E; Hoelzer D; Koeffler HP
Leuk Res; 2006 Nov; 30(11):1347-53. PubMed ID: 16682076
[TBL] [Abstract][Full Text] [Related]
20. Involvement of transforming growth factor-beta and thrombopoietin in the pathogenesis of myelodysplastic syndrome with myelofibrosis.
Akiyama T; Matsunaga T; Terui T; Miyanishi K; Tanaka I; Sato T; Kuroda H; Takimoto R; Takayama T; Kato J; Yamauchi N; Kogawa K; Sakamaki S; Hirayama Y; Kohda K; Niitsu Y
Leukemia; 2005 Sep; 19(9):1558-66. PubMed ID: 16034467
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
